NCT05743764View on ClinicalTrials.gov

HU007 in Patients with Dry Eye Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

328

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

February 14, 2024

Study Completion Date

February 14, 2024

Conditions

Dry Eye Disease

Interventions

DRUG

HU007

cyclosporine 0.02%, trehalose 3%

DRUG

Restasis

cyclosporine 0.05%

DRUG

Moisview Eye drop

trehalose 3%

Trial Locations (1)

52727

Gyeongsang National University Hospital, Jinju

All Listed Sponsors

lead

Huons Co., Ltd.

INDUSTRY